Abstract
Prostate cancer is the most commonly diagnosed cancer among North American men. The recent discovery of altered genes that play an underlying role in prostate cancer development has made the sequence-specific detection of nucleic acids especially important. Multiplexed detection using electronic readout would permit sensitive, reliable, fast and inexpensive identification of molecular biomarkers in clinical settings. This would improve early diagnosis, and would provide a route towards prognosis and new therapeutic possibilities. Here we report for the first time the development of a novel chip-based, addressable array of nano-textured microelectrodes (NMEs) that can be used in automated detection of a panel of prostate cancer-related gene fusions in clinical samples. The attomolar sensitivity along with the unique multiplexing capability of this system make it superior to the previously reported electrochemical nucleic acids sensors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.